Trichosanthin interacts with and enters cells via LDL receptor family members

Biochemical and Biophysical Research Communications

Volumn 270, Issue 2, 2000, Pages 453-457

  Chan, Wah Lun ^a   Shaw, Pang Chui ^a   Tam, Siu Cheung ^a   Jacobsen, Christian ^b   Gliemann, Jørgen ^b   Nielsen, Morten S ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Choriocarcinoma cells; Receptor binding; Receptor associated protein; Ribosome inactivating protein; The 2 macroglobulin receptor LDL receptor related protein; Trichosanthin

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR; MEGALIN; TRICHOSANTHIN;

ARTICLE; EPITHELIUM CELL; HUMAN; HUMAN CELL; KIDNEY PROXIMAL TUBULE; PRIORITY JOURNAL; TROPHOBLAST;

EID: 0034643270     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2441     Document Type: Article

References (22)

1. Shaw P. C., Chan W. L., Yeung H. W., Ng T. B. Minireview: Trichosanthin - A protein with multiple pharmacological properties. Life Sci. 55:1994;253-262.
2. Jin. Y. C. Clinical study of trichosanthin. Chang H. M., Yeung H. W., Tso W. W., Koo A. Advances in Chinese Medicinal Material Research. 1985;319-326 World Scientific Publ. Co. Singapore.
3. Liu G., Liu F., Li Y., Yu S. A Summary of 402 cases of termination of early pregnancy with crystalline preparation of trichosanthin. Chang H. M., Yeung H. W., Tso W. W., Koo A. Advances in Chinese Medicinal Material Research. 1985;327-333 World Scientific Publ. Co. Singapore.
4. Wang Y., Qian R. Q., Gu Z. W., Jin S. W., Zhang L. Q., Xia Z. X., Tian G. Y., Ni C. Z. Scientific evaluation of Tian Hua Fen (THF) - History, chemistry and application. Pure Appl. Chem. 58:1985;789-798.
5. Huang, Y.1987Treatment of malignant trophoblastic neoplasia with trichosanthin. Chin. J. Integ. Tradition West Med.7, 154-155, 1987.
6. Tsao S. W., Kan K. T., Yeung H. W. Selective killing of choriocarcinoma cells in vitro by trichosanthin, a plant protein purified from root tubers of the Chinese medicinal herb Trichosanthes kirilowii. Toxicon. 24:1986;831-840.
7. Tsao S. W., Ng T. B., Yeung H. W. Toxicities of trichosanthin and alpha-momorcharin, abortifacient proteins from Chinese medicinal plants, on cultured tumor cell lines. Toxicon. 28:1990;1183-1192.
8. McGrath M. S., Hwang K. M., Caldwell S. E., Gaston I., Luk K. C., Wu P., Ng V. L., Crowe S., Daniels J., Marsh J., Deinhart T., Lekas P. V., Vennari J. C., Yeung H. W., Lifson J. D. GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage. Proc. Natl. Acad. Sci. USA. 86:1989;2844-2848.
9. Kahn J. O., Gorelick K. J., Gatti G., Arri C. J., Lifson J. D., Gambertoglio J. G., Bostrom A., Williams R. L. Safety, activity, and pharmacokinetics of GLQ223 in patients with AIDS and AIDS-related complex. Antimicrob. Agents Chemother. 38:1994;260-267.
10. Xiong Y. Z., Pan P., Xu S. Y., Zhang J., Wang Y. H., Zuo J. K., Gu Z. Study on the effects of trichosanthin on human trophoblast cells in vitro. Acta Zool. Sinica. 22:1976;172-179.
11. Cavallaro U., Nykjaer A., Nielsen M., Soria M. R. Alpha 2-macroglobulin receptor mediates binding and cytotoxicity of plant ribosome-inactivating proteins. Eur. J. Biochem. 232:1995;165-171.
12. Gliemann J. Receptors of the low density lipoprotein (LDL) receptor family in man. Biol. Chem. 379:1998;951-964.
13. Moestrup S. K., Birn H., Fischer P. B., Petersen C. M., Verroust P. J., Sim R. B., Christensen E. I., Nexø E. Megalin-mediated endocytosis of transcobalamin-vitamin-B12 complexes suggests a role of the receptor in vitamin-B12 homeostasis. Proc. Natl. Acad. Sci. USA. 93:1996;8612-8617.
14. Moestrup S. K., Gliemann J. Analysis of ligand recognition by the purified alpha 2-macroglobulin receptor. J. Biol. Chem. 266:1991;14011-14017.
15. Nykjær A., Petersen C. M., Møller B., Jensen P. H., Moestrup S. K., Holtet T. L., Etzerodt M., Thøgersen H. C., Munch M., Andreasen P. A., Gliemann. Purified alpha 2-macroglobulin receptor binds urokinase:plasminogen activator inhibitor type-1 complex. J. Biol. Chem. 267:1992;14534-14546.
16. Dai R. X., Xu G. J., Lin X. Y., Liu L. Y., Shen H. P., Zhou X. G., Gao T., Wang Y. H. Studies on injury-mechanism of trichosanthin on trophoblast cells and choriocarcinoma cells in culture. Shih Yen Sheng Wu Hsueh Pao. 26:1993;411-427.
17. Hussain M. M., Strickland D. K., Bakillah. The mammalian low-density lipoprotein receptor family. Annu. Rev. Nutr. 19:1999;141-172.
18. Moestrup S. K., Gliemann J., Pallesen G. Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res. 269:1992;375-382.
19. Jensen P. H., Christensen E. I., Ebbesen P., Gliemann J., Andreasen P. A. Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells. Cell Regulation. 1:1990;1043-1056.
20. 2-macroglobulin-proteinase complex binding: A common but not exclusive characteristic of malignant cells. In Vivo. 3:1989;7-10.
21. Christensen E. I., Birn H., Verroust P., Moestrup S. K. Membrane receptors for endocytosis in the renal proximal tubule. Int. Rev. Cytol. 180:1998;237-284.
22. Tang N. L., Chan W. L., Ke Y. O., Mak M. K., Lai F. M., Tam S. C. Acute renal failure and proximal tubule lesions after trichosanthin injection in rats. Exp. Mol. Pathol. 64:1997;78-89.